Clinical trial
Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The…
NCT00472836 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00472836 |
|---|---|
| Title | Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug |
| Official title | A Phase 1, Open-Label, Parallel Group, Multiple-Dose Study To Evaluate The Pharmacokinetics, Safety And Toleration Of CP-945,598 Administered To Subjects With Severely Impaired And Normal Renal Function |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | CP-945, 598 |
| Enrollment | 17 |
| Start date | Jun 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | May 14, 2007 |
| Last update posted | Aug 13, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: